Form 4: STAAR Surgical CFO Patrick Williams Reports Stock Vesting

Sentiment:

SEC Form 4 Filing


Patrick Williams, CFO of STAAR Surgical, reports the vesting of performance stock units and continued holdings of restricted stock units.

Summary

  • Patrick F. Williams, Chief Financial Officer of STAAR Surgical Co., reported the vesting of 2,614 shares of common stock on March 7, 2024.
  • These shares resulted from the vesting of performance stock units (PSUs) granted on March 7, 2022, based on the company's performance against pre-established financial metrics.
  • The PSUs vest in three tranches: 1/3 on March 7, 2023, 1/3 on March 7, 2024, and the remaining 1/3 to vest on March 7, 2025.
  • Following the transaction, Williams beneficially owns 45,475 shares of STAAR Surgical common stock, which includes previously granted restricted stock units (RSUs) that are subject to future vesting.
  • Williams has granted limited power of attorney to Nathaniel Sisitsky and Kathleen Determann for Section 16 reporting obligations.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing related to stock vesting. It doesn't contain any particularly positive or negative information, but the vesting of PSUs suggests the company is meeting its performance targets.

Positives

  • The vesting of performance stock units indicates that the company has met certain pre-established financial metrics, which is a positive sign.

Future Outlook

The remaining 1/3 of the performance stock units (2,614 shares) will vest on March 7, 2025, contingent on the company's performance.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency to investors regarding the holdings of company insiders.

Comparison to Industry Standards

  • Executive compensation packages often include performance-based equity grants like PSUs to align management's interests with those of shareholders.
  • Vesting schedules, such as the three-year vesting period for these PSUs, are standard practice in the industry.
  • Companies like Alcon and Johnson & Johnson also utilize similar equity-based compensation strategies for their executives.

Stakeholder Impact

  • The vesting of stock units can have a minor positive impact on shareholder sentiment as it indicates the company is achieving its performance goals.

Key Dates

DateDescription
03/07/2022Date of original grant of performance stock units (PSUs).
03/07/2023First vesting date of 1/3 of the PSUs (2,614 shares).
03/07/2024Second vesting date of 1/3 of the PSUs (2,614 shares).
03/07/2025Final vesting date of 1/3 of the PSUs (2,614 shares).
03/08/2024Date of the signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.